BioLineRx (BLRX) Interest Expenses (2011 - 2025)
BioLineRx's (BLRX) quarterly Interest Expenses came in at -$280000.0 in Q4 2025, down 107.0% year-on-year from $4.0 million in Q4 2024, and up 7.89% quarter-over-quarter from -$304000.0 in Q3 2025.
BioLineRx (BLRX) Interest Expenses (2011 - 2025) Analysis & Trends
BioLineRx's Interest Expenses history runs 14 years deep, the most recent figure standing at -$280000.0 for Q4 2025.
- On a quarterly basis, Interest Expenses fell 107.0% year-over-year to -$280000.0 in Q4 2025; TTM through Dec 2025 was -$1.3 million, a 100.31% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 million, up 85.96% from the prior year.
- Interest Expenses rose to -$280000.0 in Q4 2025 per BLRX's latest filing, from -$304000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $5.3 million in Q4 2023 and bottomed at -$2.1 million in Q2 2024.
- The 5-year median for Interest Expenses is -$289500.0 (2021), against an average of $151000.0.
- Biggest YoY gain for Interest Expenses was 101.3% in 2023; the steepest drop was 398.39% in 2023.
- Year by year, Interest Expenses stood at $1.8 million in 2021, then surged by 46.58% to $2.6 million in 2022, then soared by 101.3% to $5.3 million in 2023, then retreated by 24.1% to $4.0 million in 2024, then tumbled by 107.0% to -$280000.0 in 2025.
- Per Business Quant, the three latest BLRX Interest Expenses figures stand at -$280000.0 (Q4 2025), -$304000.0 (Q3 2025), and -$276000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 | -280,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -280,000.00 |
| Dec 31, 2025 | -280,000.00 |
| Sep 30, 2025 | -304,000.00 |
| Sep 30, 2025 | -304,000.00 |
| Jun 30, 2025 | -276,000.00 |
| Jun 30, 2025 | -276,000.00 |
| Mar 31, 2025 | -420,000.00 |
| Mar 31, 2025 | -420,000.00 |
| Dec 31, 2024 | 4.00 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Sep 30, 2024 | -1.63 Mn |
| Sep 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -2.09 Mn |
| Jun 30, 2024 | -2.09 Mn |
| Mar 31, 2024 | -929,000.00 |
| Mar 31, 2024 | -929,000.00 |
| Dec 31, 2023 | 5.27 Mn |
| Dec 31, 2023 | 5.27 Mn |
| Sep 30, 2023 | -837,000.00 |
| Sep 30, 2023 | -837,000.00 |